# The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery

> **NCT03535116** · PHASE4 · UNKNOWN · sponsor: **Dr. Chandran Medical Prof Corp** · enrollment: 100 (estimated)

## Conditions studied

- Hematoma Postoperative

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03535116
- **Lead sponsor:** Dr. Chandran Medical Prof Corp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03535116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03535116, "The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03535116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*